Ad is loading...
Ad is loading...
ADNRX vs RPMGX
ADNRX vs RPMGX Comparison
Open Charts ADNRX vs RPMGX
American Beacon ARK Transfmt Innov R6
Price$15.04
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth
Price$112.54
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
ADNRX vs RPMGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
ADNRX vs. RPMGX commentary
Nov 23, 2024
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNRX is a Sell and RPMGX is a Buy.
FUNDAMENTALS
Fundamentals
RPMGX has more cash in the bank: 31.3B vs. ADNRX (206M). RPMGX pays higher dividends than ADNRX: RPMGX (0.05) vs ADNRX (0.00). ADNRX was incepted earlier than RPMGX: ADNRX (4 years) vs RPMGX (32 years). ADNRX is a more actively managed with annual turnover of: 33.00 vs. RPMGX (21.70). ADNRX has a lower initial minimum investment than RPMGX: ADNRX (0) vs RPMGX (2500). ADNRX annual gain was more profitable for investors over the last year : 24.09 vs. RPMGX (14.99).
| ADNRX | RPMGX | ADNRX / RPMGX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 4 years | 32 years | - |
| Gain YTD | 4.735 | 12.495 | 38% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 206M | 31.3B | 1% |
| Annual Yield % from dividends | 0.00 | 0.05 | - |
| Returns for 1 year | 24.09 | 14.99 | 161% |
| Returns for 3 years | -62.84 | -13.49 | 466% |
| Returns for 5 years | N/A | 16.28 | - |
| Returns for 10 years | N/A | 37.54 | - |
View a ticker or compare two or three
VS
VS
Ad is loading...